About 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol
1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol (PubChem CID 139429445) has the molecular formula C28H24Cl4N6O2
and a molecular weight of 618.35 g/mol. Its IUPAC name is 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol.
Molecular Properties
| Compound Name | 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol |
| PubChem CID | 139429445 |
| Molecular Formula | C28H24Cl4N6O2 |
| Molecular Weight | 618.35 g/mol |
| Exact Mass | 616.07 |
| IUPAC Name | 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol |
| SMILES | OC1CN(Cc2ncc(-c3cccc(-c4cccc(-c5cnc(CN6CC(O)C6)c(Cl)n5)c4Cl)c3Cl)nc2Cl)C1 |
| InChI | InChI=1S/C28H24Cl4N6O2/c29-25-17(3-1-5-19(25)21-7-33-23(27(31)35-21)13-37-9-15(39)10-37)18-4-2-6-20(26(18)30)22-8-34-24(28(32)36-22)14-38-11-16(40)12-38/h1-8,15-16,39-40H,9-14H2 |
| InChIKey | GCNUBRPQAMHHLC-UHFFFAOYSA-N |
| XLogP | 5.23 |
| TPSA | 98.50 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 618.35 |
| LogP ≤ 5 | 5.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol?
The IUPAC name of 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol (CID 139429445) is 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol.
What is the SMILES notation for 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol?
The canonical SMILES for 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol is OC1CN(Cc2ncc(-c3cccc(-c4cccc(-c5cnc(CN6CC(O)C6)c(Cl)n5)c4Cl)c3Cl)nc2Cl)C1.
What is the InChIKey of 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol?
The InChIKey is GCNUBRPQAMHHLC-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H24Cl4N6O2/c29-25-17(3-1-5-19(25)21-7-33-23(27(31)35-21)13-37-9-15(39)10-37)18-4-2-6-20(26(18)30)22-8-34-24(28(32)36-22)14-38-11-16(40)12-38/h1-8,15-16,39-40H,9-14H2.
What are the key properties of 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol?
1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol has a molecular weight of 618.35 g/mol, XLogP of 5.23, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[3-chloro-5-[2-chloro-3-[2-chloro-3-[6-chloro-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]pyrazin-2-yl]methyl]azetidin-3-ol is sourced from PubChem (CID 139429445), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).